MMAF intermediate 1
MMAF intermediate 1 is an intermediate in the synthesis of MMAF. MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A[1].
Product Specifications
CAS Number
161485-82-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ADC Payload
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mmaf-intermediate-1.html
Purity
99.20
Solubility
10 mM in DMSO
Smiles
O=C(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C(OC)=O)CC2=CC=CC=C2)=O)OC)OC(C)(C)C
Molecular Formula
C24H36N2O6
Molecular Weight
448.55
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TLE1 (Transducin-like Enhancer Protein 1, E(Sp1) Homolog, Enhancer of Split Groucho-like Protein 1, ESG1) (PE)
TLE1 (Transducin-like Enhancer Protein 1, E(Sp1) Homolog, Enhancer of Split Groucho-like Protein 1, ESG1) (PE)
Lentiviral mouse Wdr59 shRNA (UAS) - Lentiviral mouse Wdr59 shRNA (UAS, RFP) plasmid
Lentiviral human STX16 shRNA (UAS) - Lentiviral human STX16 shRNA (UAS, RFP) plasmid
